Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS

Clinical trial NCT02124174 · UNKNOWN

Trial details

NCT number: NCT02124174
Sponsor: Patrick Stiff
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia AML Myelodysplastic Syndrome MDS

Start date: 2012-01-01
Primary completion: 2022-01-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.